147 related articles for article (PubMed ID: 31639530)
1. Progress in quantitative technique of circulating cell free DNA and its role in cancer diagnosis and prognosis.
Weng JL; Atyah M; Zhou CH; Ren N
Cancer Genet; 2019 Nov; 239():75-84. PubMed ID: 31639530
[TBL] [Abstract][Full Text] [Related]
2. Circulating cell-free DNA in patients with alveolar echinococcosis.
Baraquin A; Hervouet E; Richou C; Flori P; Peixoto P; Azizi A; Delabrousse E; Blagosklonov O; Umhang G; Bresson-Hadni S; Valot B; Grenouillet F;
Mol Biochem Parasitol; 2018 Jun; 222():14-20. PubMed ID: 29679605
[TBL] [Abstract][Full Text] [Related]
3. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis.
Hashimoto T; Yoshida K; Hashimoto N; Nakai A; Kaneshiro K; Suzuki K; Kawasaki Y; Shibanuma N; Hashiramoto A
Int J Rheum Dis; 2017 Jun; 20(6):722-730. PubMed ID: 27943573
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis.
Huebner H; Lubrich H; Blum S; Antoniadis S; Lermann J; Ekici A; Fasching PA; Beckmann MW; Ruebner M; Burghaus S
Reprod Biomed Online; 2021 Nov; 43(5):788-798. PubMed ID: 34493460
[TBL] [Abstract][Full Text] [Related]
5. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.
Vietsch EE; Graham GT; McCutcheon JN; Javaid A; Giaccone G; Marshall JL; Wellstein A
Cancer Genet; 2017 Dec; 218-219():39-50. PubMed ID: 29153095
[TBL] [Abstract][Full Text] [Related]
6. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
Arko-Boham B; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Doris Shackie ES; Debrah AB; Adu-Aryee NA
Cancer Genet; 2019 Jun; 235-236():65-71. PubMed ID: 31105051
[TBL] [Abstract][Full Text] [Related]
7. Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing.
Hellwig S; Nix DA; Gligorich KM; O'Shea JM; Thomas A; Fuertes CL; Bhetariya PJ; Marth GT; Bronner MP; Underhill HR
PLoS One; 2018; 13(7):e0197333. PubMed ID: 30044795
[TBL] [Abstract][Full Text] [Related]
8. Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence.
Pasternack H; Fassunke J; Plum PS; Chon SH; Hescheler DA; Gassa A; Merkelbach-Bruse S; Bruns CJ; Perner S; Hallek M; Büttner R; Bollschweiler E; Hölscher AH; Quaas A; Zander T; Weiss J; Alakus H
Sci Rep; 2018 Oct; 8(1):14941. PubMed ID: 30297788
[TBL] [Abstract][Full Text] [Related]
9. Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
Lampignano R; Neumann MHD; Weber S; Kloten V; Herdean A; Voss T; Groelz D; Babayan A; Tibbesma M; Schlumpberger M; Chemi F; Rothwell DG; Wikman H; Galizzi JP; Riise Bergheim I; Russnes H; Mussolin B; Bonin S; Voigt C; Musa H; Pinzani P; Lianidou E; Brady G; Speicher MR; Pantel K; Betsou F; Schuuring E; Kubista M; Ammerlaan W; Sprenger-Haussels M; Schlange T; Heitzer E
Clin Chem; 2020 Jan; 66(1):149-160. PubMed ID: 31628139
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of circulating cell free DNA in plasma as a biomarker of different thyroid diseases.
Caglar O; Cilgin B; Eroglu M; Cayir A
Braz J Otorhinolaryngol; 2020; 86(3):321-326. PubMed ID: 30826312
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Evaluation of the Factors Affecting Plasma Circulating Cell-Free DNA Levels and Their Application in Diagnosing Nonsmall Cell Lung Cancer.
Chen Z; Zhang S; Li C; Xu C; Zhao J; Miao L
Genet Test Mol Biomarkers; 2019 Apr; 23(4):270-276. PubMed ID: 30986099
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience.
Li M; Jia Y; Xu J; Cheng X; Xu C
Ann Hematol; 2017 Aug; 96(8):1343-1351. PubMed ID: 28623396
[TBL] [Abstract][Full Text] [Related]
13. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
Panagopoulou M; Karaglani M; Balgkouranidou I; Biziota E; Koukaki T; Karamitrousis E; Nena E; Tsamardinos I; Kolios G; Lianidou E; Kakolyris S; Chatzaki E
Oncogene; 2019 May; 38(18):3387-3401. PubMed ID: 30643192
[TBL] [Abstract][Full Text] [Related]
14. Cell-free DNA diagnostics: current and emerging applications in oncology.
Muluhngwi P; Valdes R; Fernandez-Botran R; Burton E; Williams B; Linder MW
Pharmacogenomics; 2019 Apr; 20(5):357-380. PubMed ID: 30983510
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive genotyping of metastatic colorectal cancer using circulating cell free DNA.
Shi X; Duose DY; Mehrotra M; Harmon MA; Hu P; Wistuba II; Kopetz S; Luthra R
Cancer Genet; 2019 Sep; 237():82-89. PubMed ID: 31447070
[TBL] [Abstract][Full Text] [Related]
16. Label-Free Human Disease Characterization through Circulating Cell-Free DNA Analysis Using Raman Spectroscopy.
Papadakis VM; Cheimonidi C; Panagopoulou M; Karaglani M; Apalaki P; Katsara K; Kenanakis G; Theodosiou T; Constantinidis TC; Stratigi K; Chatzaki E
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569759
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of commercial kits for purification of circulating free DNA.
Diefenbach RJ; Lee JH; Kefford RF; Rizos H
Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
[TBL] [Abstract][Full Text] [Related]
18. Circadian rhythm and circulating cell-free DNA release on healthy subjects.
Poulet G; Hulot JS; Blanchard A; Bergerot D; Xiao W; Ginot F; Boutonnet-Rodat A; Justine A; Beinse G; Geromel V; Pellegrina L; Azizi M; Laurent-Puig P; Benhaim L; Taly V
Sci Rep; 2023 Dec; 13(1):21675. PubMed ID: 38065990
[TBL] [Abstract][Full Text] [Related]
19. Circulating cell-free DNA release in vitro: kinetics, size profiling, and cancer-related gene methylation.
Panagopoulou M; Karaglani M; Balgkouranidou I; Pantazi C; Kolios G; Kakolyris S; Chatzaki E
J Cell Physiol; 2019 Aug; 234(8):14079-14089. PubMed ID: 30618174
[TBL] [Abstract][Full Text] [Related]
20. Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study.
de Vos L; Jung M; Koerber RM; Bawden EG; Holderried TAW; Dietrich J; Bootz F; Brossart P; Kristiansen G; Dietrich D
J Mol Diagn; 2020 Jul; 22(7):920-933. PubMed ID: 32361006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
